Breast cancer and autism

Area of Science:

• Oncology
• Neuroscience
• Bioethics

Background:

• A 44-year-old woman with severe autism and a history of stage I invasive ductal carcinoma experienced a recurrence.
• She is nonverbal, has significant challenges with physical examinations and medical devices due to sensory sensitivities.
• Her caregiver and sister, Susan, manages her medical decisions and prioritizes quality of life.

Purpose of the Study:

• To present a complex case study on managing breast cancer recurrence in a nonverbal autistic patient.
• To explore the ethical considerations and decision-making process when a patient cannot provide informed consent.
• To discuss the challenges in delivering medical treatment to patients with severe autism.

Main Methods:

• A detailed case review of a patient with autism spectrum disorder and breast cancer recurrence.
• Discussion of standard oncological treatment guidelines (surgery, chemotherapy, radiation).
• Analysis of ethical principles, including patient autonomy, beneficence, and quality of life.

Main Results:

• The patient initially received a mastectomy but did not receive adjuvant chemotherapy due to communication barriers and caregiver concerns.
• Recurrence was noted in the axillary lymph nodes, necessitating further treatment considerations.
• The case highlights the conflict between aggressive cancer treatment and the patient's limited capacity to consent and potential impact on quality of life.

Conclusions:

• Treatment decisions for nonverbal autistic patients with cancer require a multidisciplinary approach, prioritizing patient well-being and ethical considerations.
• Caregiver involvement and understanding of the patient's nonverbal communication are crucial.
• Balancing the benefits of cancer treatment against the potential distress and impact on quality of life is paramount.